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Abstract Monkeypox virus (MPV) causes a human disease
which resembles smallpox but with a lower person-to-person
transmission rate. To determine the genetic relationship between
the orthopoxviruses causing these two diseases, we sequenced the
197-kb genome of MPV isolated from a patient during a large
human monkeypox outbreak in Zaire in 1996. The nucleotide
sequence within the central region of the MPV genome, which
encodes essential enzymes and structural proteins, was 96.3%
identical with that of variola (smallpox) virus (VAR). In
contrast, there were considerable differences between MPV and
VAR in the regions encoding virulence and host-range factors
near the ends of the genome. Our data indicate that MPV is not
the direct ancestor of VAR and is unlikely to naturally acquire
all properties of VAR. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Smallpox, an epidemic disease of humans with a high mor-
tality rate caused by variola virus (VAR), a member of the
genus Orthopoxvirus of the family Poxviridae, is the only
example of an infectious disease that was eradicated by the
international community under the aegis of the World Health
Organization [1,2]. Two factors contributed to the success of
this unprecedented campaign: the exclusively human host
range of VAR and the availability of a highly e¡ective and
inexpensive live vaccine derived from the closely related vac-
cinia virus (VAC). Mass vaccination of populations together
with a thorough epidemiological surveillance led to the global
eradication of smallpox by 1977 [1]. Following smallpox erad-
ication, vaccination was terminated throughout the world,
resulting in a growing population that is completely unpro-
tected from VAR as well as related orthopoxviruses. This
situation provides an opportunity for zoonotic orthopoxvi-
ruses, such as monkeypox (MPV), cowpox (CPV), and bu¡a-
lopox, to spread in the human population and possibly under-
go adaptive mutations. MPV is of the highest medical concern
because it causes a human disease similar to smallpox in its
clinical manifestations and mortality rate [3]. The ¢rst case of
human monkeypox was discovered in Congo in 1970 [4]. In-
vestigations from 1981 to 1986 demonstrated that human
monkeypox is a sporadic disease caused by MPV transmission
from animals to humans in the tropical rainforest regions of
Central and Western Africa. Secondary human-to-human
spread accounted for about 28% of the cases; tertiary and
quaternary chains of transmission were rare [3]. From 1970
to 1995, 388 of the 418 recorded cases of human monkeypox
occurred in Zaire (now the Democratic Republic of the Con-
go, DRC) [5]. The number of suspected cases of human mon-
keypox in DRC exceeded 500 in 1996 and 1997, and the DRC
health authorities reported several hundred new cases in Jan-
uary 1999 [5,6]. Although most of these cases have not been
con¢rmed by laboratory testing, there is concern that human
monkeypox is increasing [7]. In addition, the clinical similar-
ities of human monkeypox and smallpox raised questions re-
garding the genetic relationships of the viruses and whether
MPV could evolve into a VAR-like virus with a high fre-
quency of human-to-human transmission [5,7,8]. Although
some preliminary genetic information indicating di¡erences
between VAR, MPV and other orthopoxviruses was obtained
by comparative analysis of restriction endonuclease site maps
and short DNA sequences [6,9^12], less than 7% of the MPV
genome sequence was in GenBank prior to this study. To
provide a de¢nitive comparison of MPV and VAR, the
DNA of MPV strain Zaire-96-I-16 (MPV-ZAI), isolated dur-
ing the 1996 outbreak of human monkeypox in Zaire [6] was
sequenced. Comparative analysis has shown that the central
genomic regions of MPV and VAR, which encode essential
enzymes and structural proteins, are nearly identical whereas
the terminal genomic regions, which encode virulence and
host-range factors, are substantially di¡erent. Mutations of
two interferon (IFN) resistance genes as well as the presence
of an interleukin-1L (IL-1L) inhibitor in MPV could contrib-
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ute to the di¡erent properties of the two viruses and may also
limit the usefulness of monkeypox as a model for smallpox.
While the extensive genetic di¡erences are reassuring and es-
tablish that MPV was not a direct ancestor of VAR, they do
not rule out future adaptation of MPV to humans, making
continued monitoring of human monkeypox of great impor-
tance.
2. Materials and methods
2.1. MPV isolation and DNA sequencing
MPV-ZAI was isolated in rhesus monkey kidney cell culture LLC-
MK2 from a scab sample of a monkeypox patient residing in the
Sankuru subregion, Kasdai Oriental, Zaire during a human monkey-
pox outbreak in 1996. Viral DNA, after the second passage in LLC-
MK2 cells, was extracted from the cytoplasm [13]. The fragments of
MPV-ZAI DNA were cloned in plasmids pMGC20 and pZEro-2.1.
The viral genome was sequenced using the Maxam-Gilbert technique
as described earlier [14] and by primer walking with an automatic
sequencer (Applied Biosystems, model ABI PRISM 310 DNA Ana-
lyzer). Each base was determined one or more times from each strand,
with no discrepancies. The genome sequence of MPV-ZAI was depos-
ited with GenBank under accession number AF380138. In addition,
the open reading frames (ORFs) that di¡ered most signi¢cantly from
those of VAR and other orthopoxviruses [15^19] were also sequenced
using the MPV strain Congo-8 (MPV-CNG) [4] DNA to determine
whether they were species- or isolate-speci¢c.
2.2. Analysis of the sequence data
Sequences were analyzed using software developed at the State
Research Center of Virology and Biotechnology ‘Vector’, Koltsovo,
Russia [20]. Protein homology searches were done with BLAST anal-
yses [21] using NCBI internet resources. Sequences alignments were
prepared using Clustal W [22]. Phylogenetic analyses were performed
with the neighbor-joining (NJ) method [23] implemented in MEGA
software [24]. The reliability of the phylogenetic relationship was sta-
tistically evaluated from 1000 bootstrap replicates.
3. Results and discussion
The 196 858 bp of MPV-ZAI DNA, comprising the entire
genome contains 190 largely non-overlapping ORFs of v60
amino acid residues as well as structural features and a GC
content of 31.1% similar to other orthopoxviruses. The se-
quence of MPV genome was compared to that of the India-
1967 (VAR-IND) [15] and Bangladesh-1975 (VAR-BSH) [25]
strains of VAR major, which caused severe disease and with
genomic sequence of the variola minor alastrim Garcia-1966
(VAR-GAR) strain, which caused relatively mild disease [18].
For simplicity, as the genomes of VAR-IND and VAR-BSH
are very similar [16], most of our references are to VAR-IND.
The coding sequence of MPV-ZAI DNA, limited by the ut-
most left and utmost right ORFs, is 195 118 bp long, whereas
those of VAR-IND and VAR-GAR are 184 151 and 185 846
bp, respectively. The greater length of the MPV DNA results
mainly from duplication of the four left terminal ORFs on the
right side of the genome as a part of terminal inverted repeat
(TIR), whereas the VAR genomes lack the repetition of these
ORFs and display very short gene-free TIRs (Fig. 1). The
degrees of identity between the overlapping genomic nucleo-
tide sequences of MPV-ZAI with VAR-IND and VAR-GAR
are 84.6 and 84.5%, respectively.
The central genomic regions of orthopoxviruses contain
mostly highly conserved essential genes [16,18]. This region
of MPV-ZAI DNA, which is delimited by ORFs C10L and
A25R, comprises 101 466 bp with an overall 96.3% identity to
the corresponding part of the VAR-IND genome. The virion
proteins encoded in this region of MPV-ZAI are 91.7^99.2%
identical in amino acid sequences to those of VAR-IND. For
comparison, the corresponding ORFs of VAR-GAR are 98.7^
100% identical to the isologs of VAR-IND. In contrast to the
central region, the two terminal areas of the genomes of
MPV-ZAI and VAR-IND exhibit considerable variation
caused by deletions (Fig. 1) and ORF truncations (Tables 1
and 2) in one DNA relative to the other. The variable termi-
nal regions of orthopoxvirus genomes contain the majority of
the virulence and host-range genes that were identi¢ed earlier
for VAC and CPV [17,19]. The amino acid sequences of the
putative virulence and immunomodulatory factors common to
MPV-ZAI and VAR-IND were 83.5^93.6% identical, com-
pared to a 97.3^100% identity between the corresponding
ORFs of VAR-GAR and VAR-IND (Table 1). Notably,
Table 1
Comparison of virulence factors of MPV-ZAI, VAR-IND, and VAR-GAR
Function MPV-ZAI VAR-IND VAR-GAR AA identityc
ORFa AAb ORFa AAb ORFa AAb ZAI/INDd IND/GARe
Chemokine binding J3R 246 G3R 253 G3R 253 83.5 99.3
Viral growth factor D3R 142 D2R 140 B3R 140 83.6 97.1
Tumor necrosis factor binding J2R 348 G2R 349 G2R 349 85.1 98.9
IFN resistance, eIF-2K homolog ^ ^ C3L 88 P3L 88 ^f 100
IFN resistance, dsRNA binding F3L 153 E3L 190 C3L 192 85.6 97.3
IFN-K/L binding B16R 352 B20R 354 D9R 355 85.6 99.2
IFN-Q binding B9R 267 B9R 266 H9R 266 90.9 98.5
Complement binding D15L 216 D12L 263 B18L 263 91.7 99.2
IL-18 binding D6L 126 D5L 126 B6L 126 92.1 99.2
Serine protease inhibitor (SPI) homolog,
apoptosis inhibitor
B19R 357 B25R 357 D14R 357 93.0 99.5
SPI homolog, apoptosis inhibitor B12R 344 B13R 344 D2R 344 93.6 99.1
IL-1L binding B14R 326 B15R 63 D4R 63 ^f 98.4
3-L-Hydroxy-N-5-steroid dehydrogenase A45L 346 A50L 61 A54L 61 ^f 98.4
aORF, open reading frame.
bAA, number of amino acids constituting the protein encoded by the ORF.
cAA identity, percent identity of deduced amino acid sequences of proteins were calculated by FASTA analysis.
dZAI/IND, comparison of corresponding ORFs of MPV-ZAI and VAR-IND.
ee IND/GAR, comparison of corresponding ORFs of VAR-IND and VAR-GAR.
f Indicates a deletion in the coding sequence of one virus relative to the other.
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MPV-ZAI and MPV-CNG have mutations that a¡ect trans-
lation of two IFN resistance genes encoding intracellular pro-
teins that are intact in VAR and other orthopoxviruses. One
of these (C3L in VAR-IND, Table 1), a homolog of eukary-
otic translation initiation factor 2K (eIF-2K), inhibits the anti-
viral activity of double-stranded RNA-dependent protein ki-
nase (PKR) by acting as a decoy [26]. Unlike VAR, the MPV
(strains ZAI and CNG) genome does not code this protein
due to multiple mutations in the corresponding gene. It has
been shown that a mutant VAC lacking this gene exhibited
IFN sensitivity, and virus yields were reduced approximately
100-fold compared to the parental virus [27]. The other IFN
resistance gene (E3L in VAR-IND, Table 1), present in VAR
and other orthopoxviruses, is expressed from the ¢rst or sec-
ond methionine as a long or short form, respectively [28] (Fig.
2A). The long form contains an N-terminal domain that in
VAC mediates binding to Z-DNA, nuclear localization, and
PKR interaction and is required for virulence [29]. Both the
short and long forms contain the C-terminal domain, which
binds double-stranded RNA, inhibits activation of IFN-in-
duced PKR and 2-5A-synthetase and is required for IFN re-
sistance and host range of VAC [30,31]. Interestingly, the N-
terminal Z-DNA binding motif is also present in the cellular
dsRNA-binding protein adenosine deaminase [32]. MPV
strains ZAI and CNG have an apparent mutation in the ¢rst
translation initiation codon and downstream non-sense muta-
tions so that only the short form can be translated (Fig. 2A).
It would seem likely that both mutations a¡ecting IFN resis-
tance would be attenuating in vivo, possibly contributing to
the less e⁄cient person-to-person spread of MPV compared to
VAR.
MPV also encodes a form of the complement-binding pro-
tein with only three short consensus repeats instead of four
found in other orthopoxviruses [17,33] (Fig. 2B). Although,
the MPV protein retains some complement-inhibitory activity
in vitro, the e¡ect of one less repeat has not been quanti¢ed
[34]. On the other hand, MPV encodes a secreted IL-1L-bind-
ing protein and 3-L-hydroxy-N-5-steroid dehydrogenase, dis-
covered originally in VAC [35,36], whereas the VAR strains
do not have intact versions of these ORFs (Table 1)
[18,37,38]. Notably, deletion of the VAC gene encoding the
IL-1L-binding protein has been correlated with fever and
pathogenicity [39]. Thus, in this case the presence of the IL-
1L-binding protein in MPV may contribute to its lower ability
to cause disease than VAR.
ORFs encoding proteins with ankyrin repeats, some of
which have host-range functions (orthopoxviral isologs of
the MPV-ZAI D7L and C1L, Table 2), comprise the largest
orthopoxvirus gene family [17,40]. Of the 10 genes belonging
to this family (Table 2), the one corresponding to B19R of
VAR-IND is deleted in the MPV-ZAI genome and the one
corresponding to MPV-ZAI gene D1L is deleted in both VAR
strains. In addition, four VAR genes in this family (D6L,
D7L, C1L, and O3L in VAR-IND) are truncated relative to
Fig. 1. Schematic representation of the terminal species-speci¢c variable genomic regions of MPV-ZAI and VAR-IND. TIRs are designated
with arrows, and regions of short tandem terminal repeats are designated with rectangles. Coinciding sequences are shown by wide black
blocks; deletions in one genome relative to others are shown as lines. Borders of the variable genomic regions are marked by nucleotide num-
bers corresponding to their positions in the genomes.
Table 2
Comparison of ankyrin-like proteins of MPV-ZAI, VAR-IND, and VAR-GAR
MPV-ZAI VAR-IND VAR-GAR AA identityc
ORFa AAb ORFa AAb ORFa AAb ZAI/INDd IND/GARe
D1L 437 ^ ^ ^ ^ ^f ^
D7L 660 D6L 452 B8L 355 92.2 99.1
D9L 630 D7L 153 B12L 132 70.3 99.2
O1L 442 O1L 446 Q1L 449 95.9 99.8
C1L 284 C1L 66 P1L 66 89.4 100
B5R 561 B6R 558 H6R 558 91.8 99.6
^ ^ B19R 574 D8R 574 ^f 99.5
B17R 793 B21R 787 D10R 787 87.9 99.1
J1R 587 G1R 585 G1R 585 89.4 98.8
C1L 284 O3L 70 Q3L 70 ^f 100
aORF, open reading frame.
bAA, number of amino acids constituting the protein encoded by the ORF.
cAA identity, percent identity of deduced amino acid sequences of proteins were calculated by FASTA analysis.
dZAI/IND, comparison of corresponding ORFs of MPV-ZAI and VAR-IND.
eIND/GAR, comparison of corresponding ORFs of VAR-IND and VAR-GAR.
f Indicates a deletion in the coding sequence of one virus relative to the other.
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their MPV homologs. At this time, we can only speculate as
to how these di¡erences might a¡ect host range or virulence.
The presence of DNA in VAR that is absent from MPV
and vice versa indicated that neither virus is the direct ances-
tor of the other. To better understand genetic relationships, a
phylogenetic analysis of the terminal variable genomic regions
of four orthopoxvirus species pathogenic for humans was
made based on 117 600 bp of aligned DNA (Fig. 3). The
major and minor subspecies of VAR are closely related to
each other and MPV seems slightly more distant from VAR
than VAC. Camelpox and taterapox viruses appear closer to
VAR based on a comparison of short DNA sequences [41].
CPV may be nearest to the progenitor orthopoxvirus, as it
contains all genes collectively present in the other members
of this genus [17].
In summary, a comparative analysis of MPV and VAR
genomes indicated that MPV is a discrete species exhibiting
multiple di¡erences in virulence genes from both major and
minor strains of VAR. MPV and VAR most likely evolved
independently from an orthopoxvirus ancestor resembling
CPV that contained a more complete set of genes. Although
concerns regarding the use of VAR for bioterrorism have
prompted surrogate studies of MPV in monkeys, the genetic
di¡erences between VAR and MPV raise considerable doubts
regarding the validity of this model. Nevertheless, the severe
disease caused by MPV makes this virus important in its own
right and we need to closely monitor infection rates in Africa
to ensure that it does not undergo human adaptation by spon-
taneous or recombinational means in an unvaccinated popu-
lation with a high frequency of AIDS.
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Fig. 2. A: Alignment of amino acid sequences of orthopoxviral E3L IFN resistance factor encoded by the corresponding genes of VAR-IND,
VAR-GAR, and MPV-ZAI. Blocks containing the N-terminal adenosine deaminase Z-K domain [32] (marked gray) and C-terminal double-
stranded RNA binding motif [30] are indicated. Amino acid residues that are identical to those in VAR-IND are marked with dots; amino
acid deletions are marked with dashes. The ¢rst and second methionine residues from which begins a long or short form of the protein are
marked by asterisks above the sequence. B: Alignment of amino acid sequences of the orthopoxviral complement-binding proteins. ORFs of
VAR-IND and MPV-ZAI are shown. The conserved cysteine residues are marked with black vertical blocks, other conserved residues are
marked with gray vertical blocks. The numbers above the blocks indicate four repeating domains typical of the complement-control proteins
[33].
Fig. 3. Unrooted phylogenetic tree derived from alignments of the
nucleotide sequences in the terminal variable genomic regions of
MPV-ZAI, VAR-GAR [18], VAR-IND [15], VAC-COP (VAC strain
Copenhagen) [19], and CPV-GRI (CPV strain GRI-90) [17]. The to-
tal alignment length was 117 600 bp. NJ analysis of aligned sequen-
ces provided bootstrap con¢dence intervals (values in bold) after
1000 heuristic search replicates. ClustralX software version 1.81 was
used.
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